<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00531713</url>
  </required_header>
  <id_info>
    <org_study_id>T4-T3 hypothyreose</org_study_id>
    <secondary_id>KA 02022ms</secondary_id>
    <nct_id>NCT00531713</nct_id>
  </id_info>
  <brief_title>Effect of T4-T3 Combination Therapy Versus T4 Monotherapy in Patients With Hypothyroidism</brief_title>
  <acronym>T4-T3</acronym>
  <official_title>Effect of T4-T3 Combination Therapy Versus T4 Monotherapy in Patients With Hypothyroidism,a Double Blind Randomized Cross-Over Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Copenhagen University Hospital at Herlev</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Copenhagen University Hospital at Herlev</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To compare the effect of T4-T3 combination therapy versus T4 monotherapy in patients with
      autoimmune hypothyroidism, on stable T4-substitution therapy
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      double blind randomized cross-over study.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2003</start_date>
  <completion_date type="Actual">March 2007</completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Selv-rating scales: SF-36, SCL -90-R, BDI</measure>
    <time_frame>3 month treating</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>BMI, bioimpedance</measure>
    <time_frame>3 month treament</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">59</enrollment>
  <condition>Quality of Life</condition>
  <condition>Depression</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Usual T4 dose is given</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>20 microgram of T3 is given and 50 microgram of T4 is withdrawn</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Triiodothyronine</intervention_name>
    <description>50 microgram of the usual T4 is withdrawn and the patients is given 20 microgram of T3</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Hypothyroidism, S-TSH&gt; 20 at diagnosis,Anti-TPO &gt;300 Normal TSH (0,4-4,0) for 6
             months.

        Exclusion Criteria:

          -  &lt;18 år

          -  &gt;75 år

          -  pregnant women

          -  Thyroid cancer

          -  T3 treatment

          -  Post-partum thyroiditis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Birte Nygaard</last_name>
    <role>Principal Investigator</role>
    <affiliation>Herlev Trials</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Dept of endocrinology , Herlev Hospital</name>
      <address>
        <city>Herlev</city>
        <zip>dk-3650</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>September 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 18, 2007</study_first_submitted>
  <study_first_submitted_qc>September 18, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 19, 2007</study_first_posted>
  <last_update_submitted>September 18, 2007</last_update_submitted>
  <last_update_submitted_qc>September 18, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 19, 2007</last_update_posted>
  <keyword>hypothyroidism, quality og life, depression</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depression</mesh_term>
    <mesh_term>Hypothyroidism</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

